Suchergebnisse - (Person:"De Meyer, Sandra")

PubPharm (17)

1

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Verbinnen, T. | Fevery, B. | Vijgen, L. | +3

2

Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevir

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2015

von Fevery, B. | Susser, S. | Lenz, O. | +7

3

Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested United States clinical samples between 2006 and 2012

enthalten in: AIDS research and human retroviruses | 2015

von Lathouwers, E. | Gupta, S. | Haddad, M. | +3

4

USE OF A SULFONAMIDE COMPOUND FOR IMPROVING THE PHARMACOKINETICS OF A DRUG

enthalten in: Europäisches Patentamt | 2015

von VAN T KLOOSTER GERBEN ALBERT ELEUTHERIUS | WIGERINCK PIET TOM BERT PAUL | DE MEYER SANDRA | +2

5

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

enthalten in: Journal of hepatology | 2015

von Lenz, O. | Verbinnen, T. | Fevery, B. | +8

6

Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Susser, S. | Flinders, M. | Reesink, H. | +7

7

An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay

enthalten in: Journal of clinical microbiology | 2015

von Sarrazin, C. | Dierynck, I. | Cloherty, G. | +7

8

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region

enthalten in: Antiviral research | 2015

von Sarrazin, C. | Lathouwers, E. | Peeters, M. | +11

9

Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients : REALIZE study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2015

von Berg, T. | Andreone, P. | Pol, S. | +13

10

Trends in Darunavir Resistance-Associated Mutations and Phenotypic Resistance in Commercially Tested United States Clinical Samples between 2006 and 2012

enthalten in: Aids research and human retroviruses | 2015

von Lathouwers, E. | Gupta, S. | Haddad, M. | +3